Related Experiment Videos
Compliance with group B streptococcal disease prevention guidelines
L Chandran1, M Navaie-Waliser, N J Zulqarni
1Division of General Pediatrics, Department of Pediatrics, School of Medicine, State University of New York at Stony Brook, Stony Brook, NY, USA.
MCN. the American Journal of Maternal Child Nursing
|December 1, 2001
Summary
Clinician adherence to Group B Streptococcal (GBS) prevention guidelines for mothers and infants is suboptimal. Targeted education is needed to improve compliance and prevent early-onset GBS disease.
Area of Science:
- Obstetrics and Gynecology
- Neonatal Medicine
- Infectious Disease Prevention
Background:
- Group B Streptococcal (GBS) disease remains a significant cause of early-onset neonatal infections.
- National guidelines exist to prevent GBS disease through maternal screening and intrapartum antibiotic prophylaxis.
- Assessing clinician compliance with these guidelines is crucial for effective disease prevention strategies.
Purpose of the Study:
- To evaluate clinician adherence to national guidelines for preventing early-onset Group B Streptococcal (GBS) disease in infants.
- To identify specific areas requiring educational interventions to improve clinician compliance with GBS prevention protocols.
Main Methods:
- A retrospective cohort study involving 515 mothers and 537 infants at a tertiary medical center.
- Evaluation of clinician compliance with GBS management algorithms for pregnant women and newborns at risk.
- Data collected on antibiotic administration, antenatal cultures, and infant evaluations post-delivery.
Main Results:
- Clinician compliance with intrapartum antibiotic prophylaxis for GBS ranged from 75% to 84% when indicated.
- Antenatal GBS cultures were performed in only 65% of indicated cases, with incorrect specimen site in 91%.
- Infant evaluations and post-discharge observations met guideline recommendations in varying percentages (14%-75% and 61%-94%, respectively).
Conclusions:
- Clinician compliance with current guidelines for preventing Group B Streptococcal disease in mothers and infants is not ideal.
- Significant gaps exist in the appropriate use of antenatal cultures and antibiotic prophylaxis.
- Targeted educational initiatives are necessary to enhance clinician adherence and improve GBS disease prevention outcomes.